The global environmental crisis driven by fossil-based plastics requires a transition to sustainable, biodegradable packaging alternatives. Microbial cellulose (MC) has emerged as a high-performance biopolymer characterized by a unique nanofibrillar network and robust mechanical properties; however, its industrial adoption remains constrained by high production costs (US$ 8–15 kg -1 ) and scale-up challenges. This review provides a critical and quantitatively grounded assessment of the MC value chain, addressing the gap between laboratory-scale research and commercial viability. Evidence from the reviewed literature identifies valorizing agro-industrial residues and using SCOBY-based consortia as promising strategies to reduce culture-medium costs and improve process sustainability. Integrated evidence from Techno-Economic Analysis (TEA) and Life Cycle Assessment (LCA) studies indicates that MC-based materials would need cost reductions of approximately 69–83% to achieve economic parity with commodity plastics. The literature further highlights the development of active and intelligent packaging through MC-based composites incorporating materials such as PLA, PBAT, and bioactive agents, which have been reported to enhance barrier properties and functional performance. Analysis of the intellectual property landscape reveals a marked geographical concentration, with 55% of global patents originating in China, suggesting greater technological development and commercialization activity in Asia. Overall, the reviewed evidence supports a strategic pathway integrating sustainable feedstocks, optimized downstream processing, and innovation policies to advance the translation of MC toward competitive and circular packaging applications.
No takes yet. Share an insight, caveat, or question.
Araújo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: